Prostate cancer: Custirsen fails to improve outcomes.

Sidaway, Peter

Prostate cancer: Custirsen fails to improve outcomes. [electronic resource] - Nature reviews. Urology 06 2017 - 327 p. digital

Publication Type: Journal Article; Comment

1759-4820

10.1038/nrurol.2017.51 doi


Docetaxel
Humans
Male
Prednisone
Prostatic Neoplasms
Prostatic Neoplasms, Castration-Resistant
Thionucleotides